Abstract:Objective To study the value of a new intracellular contrast agent ——cell penetrating peptide labeled Fluorescein-5-isothiocyanate (FITC) and MRI contrast agent, Gadopentetate dimeglumine in molecular imaging. Methods A new cell penetration peptides(CPPs)sequence LAGRRRRRRRRRK were synthesized in solid phase on the base of arginine_ (9) and were labelled with FITC(CPP_ 13 -FITC) and Gd-DTPA (CPP_ 13 -DTPA-Gd). Hepatic carcinoma cell line-HEPG_2 and mouse bone marrow stem cell was respectively stained by CPP_ 13 -FITC for different time intervals for observing the uptake and intracellular distribution.HEPG_2 in three100 mm2 culture plates was respectively incubated with CPP_ 13 -DTPA-Gd, Gd-DTPA and Dulbecco minimum essential medium for 30 min and imaged by 1.5 T MRI for studying the intracellular uptake and T_1WI signal characteristics. Results The peptide was synthesized by the manual solid-phase method successfully .The calculated molecular weight was 1792.78 and the chemical purity was over 95%.By inverted fluorescence microscope , HEPG_2 and mouse stem cell could transport CPP-FITC in cytoplasm and nuclear in 10 min .By MR imaging , CPP-DTPA-Gd could be uptake by HEPG_2 in 30min and had a short T_1 short T_2 signal, furthermore. T_1WI signal intensity ratio between in-tube (Ii)and out-tube(Io) in three groups of three scan slices were shown below:Ii1/Io of group 1 (Group 1 was the cell incubated by CPP_ 13 -DTPA-Gd ) respectively was 2.84、2.60、2.48; Ii1/Io of group 2 (Group 2 was the cell incubated by DTPA-Gd) respectively is 1.15、1.11、1.12; Ii1/Io of group 3 (Group 3 was the controled cell ) respectively was 1.15、1.11、1.11.By ANVOA analysis ,the signal intensity among group 1、group 2 and group 3 had significant difference(F_ (1,2) =201.88 P0.001 , F_ (1,3) =206.37 P0.001) meanwhile, the signal intensity between Group 2 and Group 3 had no difference (F_ (2,3) =0.529 P=0.507).Conclusion The new constructed cell penetration peptide on the base of the polyargnine can translocate cell by carrying FITC and MRI contrast agent-DTPA-Gd and the intracellular concentrations are readily detectable by MR imaging which suggest a new way for MR molecular imaging.

Construction, Expression and Activity Assay of A Novel Cell Penetrating Peptide

Intracellular Delivery of Native Proteins Facilitated by Cell-Penetrating Poly(disulfide)s.

Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.

Expression, Purification and Transduction Activity Identification of TAT-NEP1-40

Biological Activity Study on High Efficient Human-derived Cell-penetrating Peptide

Cell-penetrating Peptides Mediated Protein Cross-Membrane Delivery and Its Use in Bacterial Vector Vaccine.

Preparation and bioactivity of anti-Newcastle disease virus-phosphoprotein cytoplasmic transduction peptide antibody

Structure Optimisation to Improve the Delivery Efficiency and Cell Selectivity of a Tumour-Targeting Cell-Penetrating Peptide

A Novel Recombinant Protein Tat-Gfp-Kdel with Dual-Function of Penetrating Cell Membrane and Locating at Endoplasm Reticulum

Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs

Molecular Imaging of a Cell-Penetrating Peptide Labeled Fluorescein-5-isothiocyanate and MR Contrast Agents: Gadopentetate Dimeglumine

Discovery of endosomalytic cell-penetrating peptides based on bacterial membrane-targeting sequences

A high hydrophobic moment arginine-rich peptide screened by a machine learning algorithm enhanced ADC antitumor activity

Genetic Fusion of Transacting Activator of Transcription Peptide to Cyclized Green Fluorescence Protein Improves Stability, Intracellular Delivery, and Tumor Retention

TAT-Mediated Protein Transduction of Nogo Extracellular Peptide 1-40 and Its Biological Activity

Comparison of four different peptides to enhance accumulation of liposomes into the brain.

Harnessing the capacity of cell-penetrating peptides for drug delivery to the central nervous system.

Synthesis, characterization, and evaluation of novel cell-penetrating peptides based on TD-34

Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury

Characterisation of cell-penetrating peptide-mediated peptide delivery

Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides